LYNNE DIGENNARO: Open Payments
NPI 1922069046 · VERNON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 82 payments from 25 companies in 2025. Trend: 2023 $851 · 2024 $1,071 · 2025 $1,442
Food & beverage: $1,442
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $198 |
| ABBVIE INC. | 10 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $146 |
| Exact Sciences Corporation | 5 | $105 |
| PFIZER INC. | 4 | $83 |
| Novo Nordisk Inc | 5 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 6 | $73 |
| Astellas Pharma US Inc | 4 | $73 |
| GlaxoSmithKline, LLC. | 3 | $61 |
Products named: CAPLYTA, MOUNJARO, Cologuard Collection Kit, Kerendia, VOQUEZNA, Veozah, UBRELVY, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
